Physician profile
Crystal Mcleod
NPI 1417213455
$394.76
in general payments reported to CMS, 2019-2025
9 companies · $32.29 in 2025
The $32.29 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.52 · 2020: $124 · 2021: $42.56 · 2022: $32.58 · 2023: $99.63 · 2024: $23.64 · 2025: $32.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $94.17 | 2020-2025 | Elaprase |
| Glaxosmithkline, LLC. | $91.48 | 2020-2023 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $64.16 | 2021-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $58.45 | 2019-2023 | Vaxneuvance, Proquad, Gardasil 9 |
| Phadia US INC. | $22.53 | 2020 | |
| Pfizer INC. | $17.83 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.67 | 2020 | |
| Sanofi Pasteur INC. | $17.59 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Mcleod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.